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The antibacterial effect of cranberry juice and the organic acids therein on infection by
uropathogenic Escherichia coli was studied in an experimental mouse model of urinary
tract infection (UTI). Reduced bacterial counts were found in the bladder (P < 0.01)
of mice drinking fresh cranberry juice. Commercially available cranberry juice cocktail
also significantly reduced (P < 0.01) bacterial populations in the bladder, as did the
hydrophilic fraction of cranberry juice (P < 0.05). Quinic, malic, shikimic, and citric
acid, the preponderant organic acids in cranberry juice, were tested in combination and
individually. The four organic acids also decreased bacterial levels in the bladder when
administered together (P < 0.001), and so did the combination of malic plus citric acid
(P < 0.01) and malic plus quinic acid (P < 0.05). The other tested combinations of the
organic acids, and the acids administered singly, did not have any effect in the UTI model.
Apparently, the antibacterial effect of the organic acids from cranberry juice on UTI can
be obtained by administering a combination of malic acid and either citric or quinic acid.
This study show for the first time that cranberry juice reduce E. coli colonization of the
bladder in an experimental mouse model of urinary tract infection and that the organic
acids are active agents.
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INTRODUCTION
Urinary tract infection (UTI), most frequently caused by Escherichia coli, is one of the most
common bacterial infections in humans (Foxman, 2014). Up to 40–50% of women will suffer from
UTI at least once during their lifetime (Foxman, 2003). This high prevalence and the worrying rise
in antibiotic resistance among uropathogens emphasize the need for new approaches for treating
and preventing UTIs. For many years, cranberry juice has been used as a remedy to prevent
and cure UTIs (Jepson et al., 2012; Wang et al., 2012). The beneficial effect of cranberry juice
against UTI has been debated in the literature and clinical studies have shown conflicting results;
however some studies have shown a protective effect of cranberry juice against UTI (Reviewed
by Jepson et al., 2012; Wang et al., 2012; Blumberg et al., 2013; Vasileiou et al., 2013). Cranberry
juice is known to inhibit cellular adherence of uropathogenic E. coli strains expressing P fimbriae
in vitro (Ofek et al., 1991; Weiss et al., 1998). Cranberry proanthocyanidins trimers (MW 8–900),
were found to abolish in vitro adherence of P-fimbriated E. coli to cellular structures containing
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α-Gal (1→4) β-Gal binding sites similar to those on uroepithelial
cells (Foo et al., 2000a,b). Urine from mice drinking cranberry
juice instead of water had bacterial anti-adherence activity in
vitro (Sobota, 1984). The same activity was observed in urine
from mice given drinking water in which proanthocyanidins
were dissolved (Howell et al., 2001). This could indicate
that a bioactive cranberry proanthocyanidin metabolite was
present in the urine preventing adhesion (Howell, 2002). A key
characteristic of cranberry juice is the low pH of 2.5 (Hong
and Wrolstad, 1986) as well as the unique blend of the organic
acids, quinic, malic, shikimic, and citric acid (Jensen et al.,
2002), with quinic acid being the most preponderant of the
four. The concentration of quinic acid, and the ratio of the
concentration of quinic acid to malic acid of 1.36 ± 0.12 are
relatively constant (Hong and Wrolstad, 1986; Kuzminski, 1996;
Jensen et al., 2002) and are used to calculate percentage of
cranberry content in juice drinks and to assess cranberry juice
authenticity (Kuzminski, 1996). Major sugars present are glucose
and fructose at a glucose-fructose ratio of 3.55, which is unusual
for a fruit juice (Kuzminski, 1996). Citric and malic acid are
used as food preservatives, being capable of inhibiting a wide
variety of microorganisms, including Gram-negative bacteria
(Doores, 1993). In addition to acidification, citric acid also
functions as a metal-chelating agent (Verhoff, 1986) and may
possibly exert its antimicrobial activity by disruptive action on
the outer membrane (Helander and Mattila-Sandholm, 2000).
Quinic acid might be metabolized to hippuric acid, which is
a strong antibacterial agent (Fellers et al., 1933). However, the
active compounds responsible for the effect of cranberry juice in
UTI has not yet been fully elucidated.
Here, we investigated the antibacterial effect of cranberry juice
and the organic acids therein on UTI using a mouse model
of long-term ascending urinary tract infection. We show that
cranberry juice inhibits E. coli bladder colonization and that the
organic acids are active agents.
MATERIALS AND METHODS
Bacterial Strain and Preparation of
Inoculum for Infection Studies
E. coli C175-94, a clinical UTI isolate, was used for the infection
studies. It belongs to serotype O8:K48:H9 and express type
1 fimbriae but not P fimbriae (Struve and Krogfelt, 1999).
For infection studies, the bacteria were grown overnight at
37◦C in static Luria broth (Statens Serum Insitut), centrifuged
at 6,500 g for 10 min and the pellet resuspended in PBS
(130 mM NaCl, 8 mM Na2HPO4, 2 mM KH2PO4, pH
7.4; Statens Serum institut) to a concentration of ∼1010
CFU/ml.
Mouse Model of Ascending UTI
Six- to eight-week old, outbred albino female mice, Ssc:CF1,
30 ± 2 g (SSI) were used. The mice were housed six to
a cage and at all times provided free access to feed and
water (control group) or treatment solutions. The model used
was described in detail previously (Hvidberg et al., 2000).
Anesthetized mice were inoculated transurethrally with 50µl
bacterial suspension containing ∼5 × 108 CFUs using plastic
catheters. The catheter was carefully inserted via the urethral
orifice until it reached the top of the bladder and the bacterial
suspension was slowly injected into the bladder. The catheter was
immediately removed after inoculation and the mice subjected
to no further manipulations until sacrifice. The mice were
sacrificed 7 days after inoculation. For recovery of bacteria,
bladders, and kidneys were aseptically collected in 0.9% saline
and homogenized using a sterile grinder (IKA RW16 Basic),
and serial dilutions were plated on selective media. All animal
experiments were conducted under the auspices of the Danish
Animal Experiments Inspectorate, the Danish Ministry of
Justice.
Treatment Studies
After inoculation of the mice, the drinking water was substituted
with cranberry juice or bioactive compounds in water for the
rest of the experiment. A 7 day treatment period was chosen
to obtain as long a treatment period as possible but at the
same time avoiding the mice cleared the infection spontaneously.
The control group and the treated groups all consisted of six
mice in each trial. Most of the treatments were repeated two
or more times in independent trials and the data were pooled
and represented in Table 1. The reproducibility of the control
group’s infections rates in the independent trials were tested
statistically with the Kruskal-Wallis test and found not to vary
significantly.
Cranberry Juice and Organic Acids Used
for Treatment Studies
Both commercially available and fresh cranberry juice were
tested. Cranberry Juice Cocktail from Ocean Spray R© is a 27%
single-strength cranberry juice sold in grocery stores. It contains
water, high fructose corn syrup, cranberry juice concentrate,
and ascorbic acid. Fresh cranberry juice and the preparative
isolation of the hydrophilic fraction of cranberry juice were
prepared as previously described (Jensen et al., 2002). Frozen
American cranberries (Vacciniummacrocarpon) from Northland
Cranberries R© were thawed at 5◦C overnight and 1 kg of the
berries blended with 700ml of deionized water for 5 min
in a Waring Commercial Blendor. The pulp was centrifuged
at 420 g for 15 min and the supernatant was filtered and
adjusted to a volume of 1,000ml fresh cranberry juice. The
hydrophilic fraction was made by applying 200ml cranberry
juice on 20 g of RP-18 LiChroprep, 40–63µm silylated silica gel
(Merck) in a 300 × 20mm column activated with methanol
and washed with deionized water. The column was eluted with
300ml water and the eluates were pooled and evaporated in a
vacuum evaporator at 40◦C to the volume of the applied juice
(200ml). The major constituents of the hydrophilic fraction
were sugars (fructose and glucose), organic acids (quinic, malic,
citric, and shikimic acid) and iridoid glycosides (monotropein
and 6,7-dihydromonotropein; Jensen et al., 2002). Eluting the
column with 96% ethanol (500ml) gave the ethanolic fraction.
The eluate was concentrated to remove the ethanol in a
rotavapor (Büchi Rotatvapor-R) at 40◦C and kept at −20◦C.
Before use the residue was redissolved in deionized water
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TABLE 1 | Effect on median CFU per g bladder and urinary pH after administration of the specified agents in the drinking water.
Treatment Sample n Median (CFU) Interquartile ranges (CFU) Fluid intake/mouse/day (ml ± s.d.) Urinary pHb
Control group (Water) Bladder 47 5.4 × 104 (3.1 × 104–1.8 × 105) 7.9 ± 2.2 6.5 ± 0.2
Cranberry juice cocktail Bladder 10 1.9 × 104* (1.5 × 104–8.1 × 104) 4.2 ± 0.3 –
Fresh cranberry juice Bladder 35 2.9 × 104** (1.6 × 104–6.0 × 105) 3.0 ± 0.5 5.8 ± 0.1
Hydrophilic fraction Bladder 17 3.0 × 104* (6.3 × 103–6.4 × 104) 3.9 ± 0.3 –
Mixture of organic acidsa Bladder 36 2.6 × 104*** (1.0 × 104–5.0 × 104) 3.1 ± 0.7 5.8 ± 0.1
aMixture of citric, malic, quinic, and shikimic acid in concentrations corresponding to the concentrations found in fresh cranberry juice.
bControl n = 14, fresh cranberry juice n = 12; organic acids n = 4.
P-values indicated in the table: *P = 0.01–0.05, **P = 0.001–0.01, ***P < 0.001.
to volume corresponding to the applied juice (500ml). The
ethanolic fraction of cranberry juice contained no sugars or
organic acids but some not identified compounds, among them
anthocyanins.
The organic acids used are commercially available
(–)-quinic acid (1β,3α,4α,5β-tetrahydroxycyclohexane
carboxylic acid) (Aldrich), L-(–)-malic acid (S-hydroxy-succinic
acid) (Fluka), (–)-shikimic acid [(–)-3α,4α,5β-trihy-droxy-
cyclohexene-1-carboxylic acid] (Aldrich), and citric acid
(2-hydroxy-1,2,3-propane-tricarboxylic acid) (Riedel-de
Haën). A mixture of the four organic acids, in concentrations
corresponding to those found in the hydrophilic fraction of
cranberry juice, was tested as well as the acids separately or
in mixtures two by two. The concentration of organic acids in
the hydrophilic fraction of cranberry juice were 0.74% (w/v)
quinic, 0.53% (w/v) malic, 0.03% (w/v) shikimic, and 0.78%
(w/v) citric acid, which gave a total concentration of 2.1% (w/v).
For the PBS experiment, PBS (130 mM NaCl, 8 mM Na2HPO4,
2 mM KH2PO4, pH 7.4; SSI) was pH adjusted to pH 3.0 with
HCl.
Statistical Methods
The bacterial counts of infected bladders in each treatment group
were compared to the control group using the Mann-Whitney
U-test. P < 0.05 were considered significant. All statistical
calculations were performed by use of the GraphPad Prism
software.
RESULTS
Commercially Available and Fresh
Cranberry Juice Significantly Reduce
Bacterial Counts in Infected Bladders
The mice in the control groups drinking only water were
infected with a median of 5.4 × 104 CFU per g bladder
at sacrifice day 7 after inoculation (Table 1). Treatment with
both commercially available Cranberry Juice Cocktail and
fresh cranberry juice reduced the CFU in the bladder by
65% (P < 0.01) and 47% (P < 0.01), respectively (Table 1).
Also treatment with the hydrophilic fraction of cranberry
juice decreased CFU in the bladder by 44% (P < 0.05;
Table 1) whereas treatment with the ethanolic fraction of
cranberry juice had no effect. Only very few mice had
kidney infection and the bacterial counts were low prohibiting
analysis of treatment effect in the kidneys (Results not
shown).
Combinations of the Most Prevalent
Organic Acids in Cranberries Has an Effect
against Bladder Infection
The most prevalent organic acids from cranberry juice,
citric-, malic-, quinic-, and shikimic acid were tested in
concentrations corresponding to their respective concentration
in fresh cranberry juice. The organic acids were tested as a
mixture of four, as well as in combination two by two and
individually. Treatment with a mixture of all four organic acids
decreased the CFU in the bladder by 52 % (P < 0.001; Table 1).
Treatment with a combination of malic- and citric acid or malic-
and quinic acid decreased the CFU in the bladder by 47% (P <
0.01) and 81% (P < 0.05), respectively. Treatment with the
other combinations of acids namely quinic plus shikimic acid;
quinic plus citric acid; citric plus shikimic acid; and malic plus
shikimic acid or each organic acid separately had no effect.
Also treatment with quinic or citric acid in concentrations
corresponding to the total concentration of the four acids did not
have an effect.
Intake of Fluid with Low pH Do Not Have
an Effect on Bladder Infection
To test if oral administration of a fluid with a low pH
but without organic acids had any effect, we treated the
mice with phosphate buffer pH 3. The treatment did not
reduce the bacterial counts of infected bladders (data not
shown).
Mice Treated with Cranberry Juice or
Solutions of Organic Acids Has Lower
Fluid Intake and Lower Urinary pH
Mice given cranberry juice or solutions of organic acids instead
of drinking water drank less than the amount of water consumed
by the control group. It could be speculated that the control
group drank more due to the infection; however, the amount
consumed correspondedwith what has been previously described
for non-infected mice (Bachmanov et al., 2002). Rather the
lower amount consumed by treated mice may be due to the
astringent and sour taste of cranberry juice and the organic
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acids. Importantly, no correlation between fluid intake and
reduced CFU could be observed. Thus, addition of quinic
acid to the drinking water afforded the lowest consumption
of fluid (1.8 ml per day) but had no effect on the number
of CFUs, whereas Cranberry Juice Cocktail was consumed
in an amount close to pure water (5.8 and 6.5 ml/day,
respectively) and significantly reduced the bacterial count in
infected bladders. Thus, the observed effect do not appear to be
solely related to a more concentrated urine due to a low fluid
intake.
The treatments were found to influence urinary pH. Urinary
pH was 6.5 in mice drinking water but was lowered to 5.8 in mice
drinking cranberry juice or organic acids (Table 1).
DISCUSSION
The efficacy of treatment with cranberry juice or with
constituents in cranberry juice was here, to the best of our
knowledge, for the first time investigated in an experimental
UTI mouse model. Our results revealed that oral administration
to mice of commercially available Cranberry Juice Cocktail,
fresh unsweetened cranberry juice, the hydrophilic fraction
of cranberry juice, a combination of quinic, malic, citric,
and shikimic acid, significantly reduced the number of
viable organisms recovered from the bladder (Table 1). The
mice consumed more commercially available Cranberry Juice
Cocktail than fresh cranberry juice, perhaps due to the
higher sugar content in the commercial drink and thereby
more palatable taste. This may explain why the treatment
effect of the commercial juice were higher than of the fresh
juice.
Cranberry juice, have long been used for the prevention
and treatment of UTIs. Some clinical studies have shown a
prophylactic effect of cranberry juice against UTI in women
although conclusions of different studies have been inconsistent
(Reviewed by Jepson et al., 2012; Wang et al., 2012; Blumberg
et al., 2013; Vasileiou et al., 2013).
Several in vitro studies have showed that cranberry juice
possess antibacterial (Lee et al., 2000; Puupponen-Pimia
et al., 2001; Nogueira et al., 2003), antifungal (Swartz and
Medrek, 1968), antiviral (Konowalchuk and Speirs, 1978), and
antiadhesive (Sobota, 1984; Schmidt and Sobota, 1988; Zafriri
et al., 1989; Ofek et al., 1991; Ahuja et al., 1998; Weiss et al., 1998;
Habash et al., 1999; Burger et al., 2000, 2002; Reid et al., 2001)
properties.
We investigated the effect of oral administration of a mixture
of quinic, malic, shikimic, and citric acid in the concentrations
found in cranberry juice. The mixture of organic acids was
comparable with cranberry juice in the effect of decreasing the
number of CFU in the mouse bladder. The effect of treatment
with the organic acids from cranberry juice on CFU in the
bladder is interesting since the antibacterial effect of organic
acids in cranberry juice have only been sparsely investigated.
An effect of oral administered organic acids against diarrhea
has been previously described (Tsiloyiannis et al., 2001). Organic
acids, among them citric and malic acid were found to have a
preventive effect on diarrhea in piglets. Post-weaning diarrhea
of piglets is caused mainly by Enterotoxigenic E. coli (ETEC)
strains (Tsiloyiannis et al., 2001). Groups were compared with
regard to the appearance of clinical signs, mortality, weight
gain, and feed conversion. All groups supplemented with
organic acids had reduced incidence and severity of diarrhea,
and performed significantly better than the negative group.
The study indicates, that organic acids have an antibacterial
and/or anti-adhesive effect on diarrhea causing ETEC strains
in piglets (Tsiloyiannis et al., 2001). Our study indicates,
that a similar effect on UPEC strains occur in the urinary
tract.
In the experimental UTI model, the mice were inoculated
directly in the bladder. Therefore, the antibacterial effect must
occur at this site and the active components must be excreted in
the urine. The organic acids tested in this experiment are likely
to be excreted in the urine. Blatherwick and Long observed in
1923 that the excretion of both titratable, organic, and hippuric
acid was elevated after the ingestion of cranberries (Blatherwick
and Long, 1923). Quinic acid in cranberries might bemetabolized
to hippuric acid (Quick, 1931; Gonthier et al., 2003), which is
a strong antibacterial agent (Fellers et al., 1933). Studies have
shown that consuming large amounts of lemon, blackcurrant,
and orange juice leads to a higher urinary excretion of citric
acid (Wabner and Pak, 1993; Seltzer et al., 1996; Kessler et al.,
2002). It is likely, that consumption of large amounts of malic
acid would also lead to an increased urinary excretion of this
acid.
We measured pH in the urine from infected mice drinking
either water or cranberry juice and found a pH of 6.5 ± 0.2
and 5.8 ± 0.1, respectively. Our observation supports previous
studies, which reported that cranberry juice functions as a
urinary acidifier even in moderate amounts (Blatherwick,
1914; Blatherwick and Long, 1923; Bodel et al., 1959;
Kahn et al., 1967; Light et al., 1973; Kinney and Blount,
1979; Schultz, 1984; Jackson and Hicks, 1997; Kessler et al.,
2002).
Previous studies have shown that proanthycyanidins in
cranberry juice have anti-adhesive effect against P-fimbriated
E. coli (Foo et al., 2000a,b; Howell et al., 2001). Our study
revealed that another antibacterial factor from cranberry juice
involved in reducing UTI in a mouse model is the organic acids.
The E. coli isolate used in the present study did not possess P
fimbriae which may explain why the effect of cranberry juice
and the combinations of organic acids were comparable. It could
be speculated that a relatively higher effect of cranberry juice
would be observed against urinary tract infection caused by a
P-fimbriated E. coli strain. This should be investigated in future
studies.
This study is to the best of our knowledge, the first to
provide evidence of an antibacterial effect of consumption
of cranberry juice and combinations of its organic acids by
use of a mouse model of urinary tract infection. The active
treatments reduced bacterial counts in the bladder but did not
cure the infection, indicating that cranberry juice is not a definite
treatment but it may promote clearance of the infection for
instance in combination with antibiotics. Future studies designed
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at investigating the effect of organic acids from cranberries in
humanUTIs could facilitate the development of a functional food
or drink containing these organic acids.
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